Qifu Yixin Formula Improves Heart Failure by Enhancing β-Arrestin2 Mediated the SUMOylation of SERCA2a

References

• Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: a Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145(18):e895–e1032. doi:10.1161/CIR.0000000000001063
   PubMed Web of Science ®Google Scholar
• Bragazzi NL, Zhong W, Shu J, et al. Burden of heart failure and underlying causes in 195 countries and territories from 1990 to 2017. Eur J Prev Cardiol. 2021;28(15):1682–1690. doi:10.1093/eurjpc/zwaa147
   PubMed Web of Science ®Google Scholar
• Becher PM, Lund LH, Coats A, Savarese G. An update on global epidemiology in heart failure. Eur Heart J. 2022;43(32):3005–3007. doi:10.1093/eurheartj/ehac248
   PubMed Web of Science ®Google Scholar
• Zhihao L, Jingyu N, Lan L, et al. SERCA2a: a key protein in the Ca(2+) cycle of the heart failure. Heart Fail Rev. 2020;25(3):523–535. doi:10.1007/s10741-019-09873-3
   PubMed Web of Science ®Google Scholar
• Yla-Herttuala S. Gene Therapy for Heart Failure: back to the Bench. Mol Ther. 2015;23(10):1551–1552. doi:10.1038/mt.2015.158
   PubMed Web of Science ®Google Scholar
• Kho C, Lee A, Jeong D, et al. SUMO1-dependent modulation of SERCA2a in heart failure. Nature. 2011;477(7366):601–605. doi:10.1038/nature10407
   PubMed Web of Science ®Google Scholar
• McCrink KA, Maning J, Vu A, et al. beta-Arrestin2 improves post-myocardial infarction heart failure via Sarco(endo)plasmic Reticulum Ca(2+)-ATPase-dependent positive inotropy in cardiomyocytes. Hypertension. 2017;70(5):972–981. doi:10.1161/HYPERTENSIONAHA.117.09817
   PubMed Web of Science ®Google Scholar
• James P, Inui M, Tada M, Chiesi M, Carafoli E. Nature and site of phospholamban regulation of the Ca2+ pump of sarcoplasmic reticulum. Nature. 1989;342(6245):90–92. doi:10.1038/342090a0
   PubMed Web of Science ®Google Scholar
• Zhaohui X, Yihang Z, Tianyun S, et al. Clinical effect of qifu yixin prescription on chronic heart failure in patients with syndrome of heart qi deficiency. Zhongguo Shi Yan Fang Ji Xue Za Zhi. 2023;29(23):98–105.
   Google Scholar
• Xinting W, Cheng L, Lei S, et al. Study on mechanism of AACO prescription for regulating TGF-β1/Smad3 signaling pathway to protect myocardial fibrosis in mice with chronic heart failure. Zhongguo Zhongyiyao Xinxi Zazhi. 2023;30(01):103–108.
   Google Scholar
• Wang Q, Liu Y, Fu Q, et al. Inhibiting insulin-mediated beta2-adrenergic receptor activation prevents diabetes-associated cardiac dysfunction. Circulation. 2017;135(1):73–88. doi:10.1161/CIRCULATIONAHA.116.022281
   PubMed Web of Science ®Google Scholar
• Zhuang L, Jia K, Chen C, et al. DYRK1B-STAT3 drives cardiac hypertrophy and heart failure by impairing mitochondrial bioenergetics. Circulation. 2022;145(11):829–846. doi:10.1161/CIRCULATIONAHA.121.055727
   PubMed Web of Science ®Google Scholar
• Poole-Wilson PA, Swedberg K, Cleland JG, et al. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial. Lancet. 2003;362(9377):7–13. doi:10.1016/S0140-6736(03)13800-7
   PubMed Web of Science ®Google Scholar
• Packer M, Fowler MB, Roecker EB, et al. Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study. Circulation. 2002;106(17):2194–2199. doi:10.1161/01.CIR.0000035653.72855.BF
   PubMed Web of Science ®Google Scholar
• Maning J, Desimine VL, Pollard CM, Ghandour J, Lymperopoulos A. Carvedilol selectively stimulates betaArrestin2-dependent SERCA2a activity in cardiomyocytes to augment contractility. Int J Mol Sci. 2022;23(19). doi:10.3390/ijms231911315
   PubMed Web of Science ®Google Scholar
• Ye B, Zhou H, Chen Y, et al. USP25 ameliorates pathological cardiac hypertrophy by stabilizing SERCA2a in cardiomyocytes. Circ Res. 2023;132(4):465–480. doi:10.1161/CIRCRESAHA.122.321849
   PubMed Web of Science ®Google Scholar
• Louch WE, Hougen K, Mork HK, et al. Sodium accumulation promotes diastolic dysfunction in end-stage heart failure following Serca2 knockout. J Physiol. 2010;588(Pt 3):465–478. doi:10.1113/jphysiol.2009.183517
   PubMed Web of Science ®Google Scholar
• Xu XL, Ji H, Gu SY, Shao Q, Huang QJ, Cheng YP. Modification of alterations in cardiac function and sarcoplasmic reticulum by astragaloside IV in myocardial injury in vivo. Eur J Pharmacol. 2007;568(1–3):203–212. doi:10.1016/j.ejphar.2007.04.007
   PubMed Web of Science ®Google Scholar
• Su D, Li HY, Yan HR, Liu PF, Zhang L, Cheng JH. Astragalus improved cardiac function of adriamycin-injured rat hearts by upregulation of SERCA2a expression. Am J Chin Med. 2009;37(3):519–529. doi:10.1142/S0192415X09007028
   PubMed Web of Science ®Google Scholar
• Xu X, Xie X, Zhang H, et al. Water-soluble alkaloids extracted from Aconiti Radix lateralis praeparata protect against chronic heart failure in rats via a calcium signaling pathway. Biomed Pharmacother. 2021;135:111184. doi:10.1016/j.biopha.2020.111184
   PubMed Web of Science ®Google Scholar
• Dong Z, Zhao P, Xu M, et al. Astragaloside IV alleviates heart failure via activating PPARalpha to switch glycolysis to fatty acid beta-oxidation. Sci Rep. 2017;7(1):2691. doi:10.1038/s41598-017-02360-5
   PubMedGoogle Scholar
• Kho C, Lee A, Jeong D, et al. Small-molecule activation of SERCA2a SUMOylation for the treatment of heart failure. Nat Commun. 2015;6(1):7229. doi:10.1038/ncomms8229
   PubMedGoogle Scholar
• MacLennan DH, Kranias EG. Phospholamban: a crucial regulator of cardiac contractility. Nat Rev Mol Cell Biol. 2003;4(7):566–577. doi:10.1038/nrm1151
   PubMed Web of Science ®Google Scholar
• Kranias EG, Hajjar RJ. Modulation of cardiac contractility by the phospholamban/SERCA2a regulatome. Circ Res. 2012;110(12):1646–1660. doi:10.1161/CIRCRESAHA.111.259754
   PubMed Web of Science ®Google Scholar
• Wang Y, Ji Y, Xing Y, Li X, Gao X. Astragalosides rescue both cardiac function and sarcoplasmic reticulum Ca(2)(+) transport in rats with chronic heart failure. Phytother Res. 2012;26(2):231–238. doi:10.1002/ptr.3492
   PubMed Web of Science ®Google Scholar
• Mendler L, Braun T, Muller S. The ubiquitin-like SUMO system and heart function: from development to disease. Circ Res. 2016;118(1):132–144. doi:10.1161/CIRCRESAHA.115.307730
   PubMed Web of Science ®Google Scholar
• Wyatt D, Malik R, Vesecky AC, Marchese A. Small ubiquitin-like modifier modification of arrestin-3 regulates receptor trafficking. J Biol Chem. 2011;286(5):3884–3893. doi:10.1074/jbc.M110.152116
   PubMed Web of Science ®Google Scholar